Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2907994rdf:typepubmed:Citationlld:pubmed
pubmed-article:2907994lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:2907994lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:2907994lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:2907994lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:2907994lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:2907994lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:2907994pubmed:issue4lld:pubmed
pubmed-article:2907994pubmed:dateCreated1989-7-24lld:pubmed
pubmed-article:2907994pubmed:abstractTextAnti-reovirus cytotoxic effectors were found to be: (i) H-2 restricted; (ii) virus specific; (iii) non-lytic (in 4 h) for natural killer (NK)-sensitive YAC-1 cells; and (iv) positive for the Thy-1 and Lyt-2 lymphocyte markers. Thus, anti-reovirus cytotoxic effectors have the functional and phenotype characteristics of cytotoxic T lymphocyte (CTL). A significant fraction of anti-viral CTL, as well as alloreactive CTL, were also found to be positive for the asialo GM1 (ASGM1) cell surface antigen, generally considered to be a NK cell marker. ASGM1 expression on these CTL, as determined by sensitivity to antibody plus complement (C), appeared to be highly variable and dependent on two factors-the nature of the antigenic stimulus (viral vs. alloantigen), and the mouse strain from which the CTL originated. Thus, ASGM1 antigen expression on CTL appears to be regulated and may be under the control of lymphokines, development differentiation signals and/or other strain-dependent genetic factors.lld:pubmed
pubmed-article:2907994pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:languageenglld:pubmed
pubmed-article:2907994pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:citationSubsetIMlld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2907994pubmed:statusMEDLINElld:pubmed
pubmed-article:2907994pubmed:monthAuglld:pubmed
pubmed-article:2907994pubmed:issn0305-1811lld:pubmed
pubmed-article:2907994pubmed:authorpubmed-author:SearsD WDWlld:pubmed
pubmed-article:2907994pubmed:authorpubmed-author:ParkerS ESElld:pubmed
pubmed-article:2907994pubmed:authorpubmed-author:LuuT MTMlld:pubmed
pubmed-article:2907994pubmed:issnTypePrintlld:pubmed
pubmed-article:2907994pubmed:volume15lld:pubmed
pubmed-article:2907994pubmed:ownerNLMlld:pubmed
pubmed-article:2907994pubmed:authorsCompleteYlld:pubmed
pubmed-article:2907994pubmed:pagination215-26lld:pubmed
pubmed-article:2907994pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:meshHeadingpubmed-meshheading:2907994-...lld:pubmed
pubmed-article:2907994pubmed:year1988lld:pubmed
pubmed-article:2907994pubmed:articleTitleDifferential expression of the ASGM1 antigen on anti-reovirus and alloreactive cytotoxic T lymphocytes (CTL).lld:pubmed
pubmed-article:2907994pubmed:affiliationDepartment of Biological Sciences, University of California, Santa Barbara 93106.lld:pubmed
pubmed-article:2907994pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2907994pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2907994lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2907994lld:pubmed